Immunology
Global

Immunology Experts

​donald Olds ​m.sc., Mba

​President and Chief Executive Officer
immunology
NeoMed
Cambodia

Biography

Donald is in charge of the strategic planning, the corporate development, and the integration of all components of the NEOMED Institute in the local, national, and international R&D communities. Prior to be named President and CEO of the NEOMED Institute in January 2017, Donald was Chief Operating Officer of Telesta Therapeutics Inc. a publicly-listed biotechnology company (TSX: TST). At Telesta, he was responsible for finance and investor relations, manufacturing operations, business development, human resources and strategy.  Over the course of his three-year tenure, he led a successful U.S. financing to fund the U.S. commercial launch of Telesta’s bladder cancer therapeutic and negotiated a significant ex-U.S. License for the same asset.  In October 2016, he led the process that led to the successful sale of Telesta Therapeutics to a larger public biotechnology company.

Research Interest

Donald is in charge of the strategic planning, the corporate development, and the integration of all components of the NEOMED Institute in the local, national, and international R&D communities. Prior to be named President and CEO of the NEOMED Institute in January 2017, Donald was Chief Operating Officer of Telesta Therapeutics Inc. a publicly-listed biotechnology company (TSX: TST). At Telesta, he was responsible for finance and investor relations, manufacturing operations, business development, human resources and strategy.  Over the course of his three-year tenure, he led a successful U.S. financing to fund the U.S. commercial launch of Telesta’s bladder cancer therapeutic and negotiated a significant ex-U.S. License for the same asset.  In October 2016, he led the process that led to the successful sale of Telesta Therapeutics to a larger public biotechnology company.

Global Experts from Cambodia

Global Experts in Subject